• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-THK-5351、氟脱氧葡萄糖和氟贝他班PET图像在非典型阿尔茨海默病中的应用:对疾病病理生理学的图像洞察

F-THK-5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer's Disease: A Pictorial Insight into Disease Pathophysiology.

作者信息

Park Sohee, Oh Minyoung, Kim Jae Seung, Lee Jae-Hong, Yoon Young Wook, Roh Jee-Hoon

机构信息

Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

出版信息

Brain Sci. 2021 Apr 6;11(4):465. doi: 10.3390/brainsci11040465.

DOI:10.3390/brainsci11040465
PMID:33917613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8067517/
Abstract

The recent advance of positron emission tomography (PET) tracers as biomarkers in Alzheimer's disease (AD) provides more insight into pathophysiology, preclinical diagnosis, and further therapeutic strategies. However, synergistic processes or interactions between amyloid and tau deposits are still poorly understood. To better understand their relationship in focal brain changes with clinical phenotypes, we focused on region-specific or atypical AD characterized by focal clinical presentations: Posterior cortical atrophy (PCA) and logopenic variant of primary progressive aphasia (lpvPPA). We compared three different PET images with F-THK-5351 (tau), F-Florbetaben (amyloid beta, Aβ), and F-Fluorodeoxyglucose (glucose metabolism) to investigate potential interactions among pathologies and clinical findings. Whereas the amyloid accumulations were widespread throughout the neocortex, tau retentions and glucose hypometabolism showed focal changes corresponding to the clinical features. The distinctly localized patterns were more prominent in tau PET imaging. These findings suggest that tau pathology correlates more closely to the clinical symptoms and the neurodegenerative processes than Aβ pathology in AD.

摘要

正电子发射断层扫描(PET)示踪剂作为阿尔茨海默病(AD)生物标志物的最新进展,为病理生理学、临床前诊断及进一步的治疗策略提供了更多见解。然而,淀粉样蛋白和tau蛋白沉积之间的协同过程或相互作用仍知之甚少。为了更好地理解它们在伴有临床表型的局灶性脑改变中的关系,我们聚焦于以局灶性临床表现为特征的区域特异性或非典型AD:后皮质萎缩(PCA)和原发性进行性失语的logopenic变异型(lpvPPA)。我们比较了三种不同的PET图像,分别使用F-THK-5351(tau蛋白)、F-Florbetaben(淀粉样β蛋白,Aβ)和F-氟脱氧葡萄糖(葡萄糖代谢),以研究病变与临床发现之间的潜在相互作用。虽然淀粉样蛋白积累广泛分布于整个新皮质,但tau蛋白滞留和葡萄糖低代谢显示出与临床特征相对应的局灶性改变。这种明显的局部化模式在tau蛋白PET成像中更为突出。这些发现表明,在AD中,tau蛋白病变比Aβ蛋白病变与临床症状及神经退行性过程的相关性更强。

相似文献

1
F-THK-5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer's Disease: A Pictorial Insight into Disease Pathophysiology.F-THK-5351、氟脱氧葡萄糖和氟贝他班PET图像在非典型阿尔茨海默病中的应用:对疾病病理生理学的图像洞察
Brain Sci. 2021 Apr 6;11(4):465. doi: 10.3390/brainsci11040465.
2
Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles.具有正常或临界 PET 生物标志物谱的非典型阿尔茨海默病表型。
J Neurol. 2022 Dec;269(12):6613-6626. doi: 10.1007/s00415-022-11330-5. Epub 2022 Aug 24.
3
Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.在非典型阿尔茨海默病中[18F]AV-1451 PET 上 tau 摄取的区域分布、不对称性和临床相关性。
J Alzheimers Dis. 2018;62(4):1713-1724. doi: 10.3233/JAD-170740.
4
S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.S-[18F]THK-5117-PET 和 [11C]PIB-PET 成像在特发性正常压力脑积水与脑活检中确认的淀粉样蛋白-β斑块和 Tau 的关系。
J Alzheimers Dis. 2018;64(1):171-179. doi: 10.3233/JAD-180071.
5
Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.典型和非典型阿尔茨海默病中 tau、淀粉样蛋白、代谢和萎缩的影像学相关性。
Alzheimers Dement. 2018 Aug;14(8):1005-1014. doi: 10.1016/j.jalz.2018.02.020. Epub 2018 Mar 30.
6
Tau PET With F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation.使用F-THK-5351对携带APP p.D678H突变的台湾家族性阿尔茨海默病患者进行Tau正电子发射断层扫描
Front Neurol. 2019 May 22;10:503. doi: 10.3389/fneur.2019.00503. eCollection 2019.
7
Default mode network tau predicts future clinical decline in atypical early Alzheimer's disease.默认模式网络tau蛋白可预测非典型早发性阿尔茨海默病患者未来的临床衰退。
medRxiv. 2024 Apr 19:2024.04.17.24305620. doi: 10.1101/2024.04.17.24305620.
8
[F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review.[F]早期语义变异型原发性进行性失语的THK-5351正电子发射断层显像:两例报告及文献综述
BMC Neurol. 2018 Aug 8;18(1):109. doi: 10.1186/s12883-018-1115-3.
9
Tau accumulation in two patients with frontotemporal lobe degeneration showing different types of aphasia using 18F-THK-5351 positron emission tomography: a case report.两名额颞叶变性患者出现不同类型失语症时 Tau 积聚的 18F-THK-5351 正电子发射断层扫描:病例报告。
Int Psychogeriatr. 2018 May;30(5):641-646. doi: 10.1017/S1041610217002277. Epub 2017 Nov 8.
10
Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.18F-PI-2620 作为一种强效 PET 放射性示踪剂,用于阿尔茨海默病和其他神经退行性疾病中 tau 蛋白的临床评估,与 18F-THK-5351 相比。
Clin Nucl Med. 2020 Nov;45(11):841-847. doi: 10.1097/RLU.0000000000003261.

引用本文的文献

1
Amyloid β-Peptide Effects on Glucose Regulation Are Dependent on Apolipoprotein E Genotype.淀粉样β肽对葡萄糖调节的影响取决于载脂蛋白 E 基因型。
eNeuro. 2023 Apr 26;10(4). doi: 10.1523/ENEURO.0376-22.2023. Print 2023 Apr.
2
Imaging of Reactive Astrogliosis by Positron Emission Tomography.正电子发射断层扫描对反应性星形胶质细胞增生的成像
Front Neurosci. 2022 Feb 8;16:807435. doi: 10.3389/fnins.2022.807435. eCollection 2022.

本文引用的文献

1
New insights into atypical Alzheimer's disease in the era of biomarkers.生物标志物时代对非典型阿尔茨海默病的新认识。
Lancet Neurol. 2021 Mar;20(3):222-234. doi: 10.1016/S1474-4422(20)30440-3.
2
Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.18F-PI-2620 作为一种强效 PET 放射性示踪剂,用于阿尔茨海默病和其他神经退行性疾病中 tau 蛋白的临床评估,与 18F-THK-5351 相比。
Clin Nucl Med. 2020 Nov;45(11):841-847. doi: 10.1097/RLU.0000000000003261.
3
The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases.
基于深度学习的淀粉样蛋白PET图像分类在视觉上难以明确的病例中的临床可行性。
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):332-341. doi: 10.1007/s00259-019-04595-y. Epub 2019 Dec 6.
4
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.阿尔茨海默病:病理生物学与治疗策略的最新研究进展。
Cell. 2019 Oct 3;179(2):312-339. doi: 10.1016/j.cell.2019.09.001. Epub 2019 Sep 26.
5
The neuropathological diagnosis of Alzheimer's disease.阿尔茨海默病的神经病理学诊断。
Mol Neurodegener. 2019 Aug 2;14(1):32. doi: 10.1186/s13024-019-0333-5.
6
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.边缘系统为主的年龄相关性 TDP-43 脑病(LATE):共识工作组报告。
Brain. 2019 Jun 1;142(6):1503-1527. doi: 10.1093/brain/awz099.
7
Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.非典型阿尔茨海默病中 tau-PET 摄取和萎缩的纵向研究。
Neuroimage Clin. 2019;23:101823. doi: 10.1016/j.nicl.2019.101823. Epub 2019 Apr 10.
8
Tau PET imaging in neurodegenerative tauopathies-still a challenge.神经退行性 tau 病中的 tau PET 成像——仍然是一个挑战。
Mol Psychiatry. 2019 Aug;24(8):1112-1134. doi: 10.1038/s41380-018-0342-8. Epub 2019 Jan 11.
9
Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.非典型阿尔茨海默病中 tau 蛋白、代谢低下、萎缩和各向异性分数之间的区域性多模态关系。
Hum Brain Mapp. 2019 Apr 1;40(5):1618-1631. doi: 10.1002/hbm.24473. Epub 2018 Dec 13.
10
The development and validation of tau PET tracers: current status and future directions.tau蛋白正电子发射断层显像剂的研发与验证:现状与未来方向
Clin Transl Imaging. 2018;6(4):305-316. doi: 10.1007/s40336-018-0290-y. Epub 2018 Jul 20.